Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Wanbury announced the company has expanded regulatory submission for launch of new Active Pharmaceuticals Ingredients (APIs).
For Diphenhydramine HCl, company submitted DMF to Malaysia and Singapore.
The Company proposed to explore new market opportunities for Paroxetine HCl in Korea and Latin America by submitting the DMFs.
Company also received formal audit report from MFDS (Korea FDA) for its Patalganga facility stating zero observation for the inspection conducted in April 2026.
For the full year,net profit rose 116.61% to Rs 66.13 crore in the year ended March 2026 as against Rs 30.53 crore during the previous year ended March 2025. Sales rose 8.47% to Rs 650.27 crore in the year ended March 2026 as against Rs 599.51 crore during the previous year ended March 2025.